News


All News

Horsham, Pa. ? The U.S. Food and Drug Administration (FDA) has approved the biologic Stelara (ustekinumab, Centocor Ortho Biotech) for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for phototherapy or systemic therapy, according to a Centocor press release.

Going Too Far? : Derms question pediatric warning for TNF antagonists Targeting Melanoma : Researchers study tumor-specific protein as vaccine hopeful Special Report : Hair & Nails

Acne therapy is and has always been an important part of every dermatology practice. Whether we are accustomed to treating infantile acne, teenage acne, adult acne or even the Aesthetic complications of acne, therapy for acne is a complicated issue.